Synovetin Update

Hello Summarians!

Veterinary medicine, like most of medicine, runs on a working assumption: the right treatment exists.

Find it, apply it, watch the patient improve. In practice, it is rarely that clean. This week's studies sit inside that gap. Surgery can give horses with chronic laminitis real comfort when nothing else has worked.

A targeted joint treatment is producing meaningful results in arthritic dogs. And a new survey shows that managing canine skin disease depends as much on what clients can afford as on what guidelines say.

Chronic Laminitis Pain Control

This study evaluates the use of deep digital flexor tenotomy (DDFT) as a treatment for horses with chronic laminitis, a debilitating condition associated with severe pain, mechanical failure of the hoof, and poor long-term prognosis. Laminitis arises from multiple causes, including systemic inflammation, metabolic disorders, and mechanical overload, and often leads to rotation or sinking of the distal phalanx, resulting in irreversible structural damage and chronic discomfort.  

Using a retrospective review of 864 horses treated at a tertiary referral center between 2010 and 2022, the study assessed clinical outcomes, complications, and prognostic indicators associated with DDFT. Only 8% of horses underwent the procedure, reflecting its role as a selective intervention reserved for severe, refractory cases that fail to respond to medical therapy and corrective farriery. Horses selected for tenotomy typically had advanced disease characterized by persistent pain and radiographic evidence of distal phalanx rotation. 

The results demonstrated that DDFT was strongly associated with clinical improvement. Horses that underwent the procedure were approximately 20 times more likely to show improvement in comfort and function within three to six months compared to those managed non-surgically, although the wide confidence interval indicates variability and uncertainty in the magnitude of this effect. Age was also an important factor, with older horses showing increased risk of complications involving the distal phalanx. 

Despite these benefits, DDFT is not curative and carries potential complications, including hoof wall separation and persistent biomechanical abnormalities. The procedure primarily works by reducing tension from the deep digital flexor tendon, allowing improved alignment of the distal phalanx and more effective weight bearing. Outcomes are optimized when surgery is combined with meticulous corrective shoeing and long-term hoof management. 

Overall, the study supports DDFT as a valuable salvage procedure that can improve quality of life in carefully selected horses with chronic laminitis. However, its success depends heavily on appropriate case selection, timing, and integration into a comprehensive, multimodal treatment strategy, and further prospective research is needed to refine clinical guidelines.

Orsini, J. A., & Stefanovski, D. (2026). Deep digital flexor tenotomy provides pain relief and clinical comfort in horses with chronic laminitis. Journal of the American Veterinary Medical Association https://doi.org/10.2460/javma.25.12.0839

Bottom line — Valuable salvage procedure.

Synovotin Update

This study evaluated owner-reported outcomes and satisfaction following use of tin-117m (Sn-117m) radiosynoviorthesis (RSO) for the treatment of canine osteoarthritis (OA), a common, progressive joint disease associated with chronic pain, impaired mobility, and reduced quality of life. Traditional OA management in dogs is largely palliative, emphasizing symptom control rather than disease modification, which has driven interest in joint-targeted therapies such as RSO. Sn-117m, approved for veterinary use in 2019, acts locally within the joint by inducing apoptosis of inflammatory synovial macrophages, thereby reducing inflammation without significant systemic effects.  

The study used a multicenter, anonymous survey of 168 dog owners whose pets had received Sn-117m RSO. Overall, 63.1% of respondents reported being satisfied or very satisfied with treatment. Improvements in clinical signs were commonly reported, with 78.6% of dogs perceived to have reduced pain and 71.5% showing decreased interference with daily activities after initial treatment. Clinically meaningful improvement was observed in over half of treated dogs, and outcomes were often sustained or improved with repeat treatments.  

Owner satisfaction was strongly correlated with perceived clinical improvement, particularly reductions in pain and improved function. While cost, travel, and procedural logistics influenced satisfaction, clinical outcome was the most important determinant. Dissatisfaction, reported by a minority of owners, was primarily attributed to inadequate magnitude or duration of improvement rather than adverse effects. Treatment-related concerns were infrequent (6.5%) and generally mild, including transient discomfort or minor post-procedural effects.  

The findings highlight that responses to Sn-117m RSO are variable, reflecting the heterogeneous nature of OA. Importantly, owner expectations regarding treatment efficacy and durability played a central role in perceived success. Limitations include reliance on retrospective owner recall and potential response bias, as well as the absence of objective clinical outcome measures. 

Overall, Sn-117m RSO appears to provide meaningful perceived improvements in pain and function for many dogs with OA, with owner satisfaction largely driven by clinical benefit rather than logistical or financial considerations.

Vézina-Audette, R., Barnhard, J. A., Brunke, M. W., Levine, D., & Agrodnia, M. D. (2026). Owners report satisfaction and perceived improvement following Sn-117m radiosynoviorthesis in dogs with osteoarthritis. Journal of the American Veterinary Medical Association https://doi.org/10.2460/javma.26.01.0041 

Bottom line — Meaningful Improvements noted.

Spectrum Of Care For Atopy

This study evaluated how North American veterinarians diagnose and manage canine atopic dermatitis (CAD), with particular attention to how client financial constraints influence clinical decision-making. CAD is a common, chronic, and multifactorial disease requiring lifelong management rather than cure. Because its clinical signs overlap with other dermatologic conditions, diagnosis involves a stepwise process including history, examination, and repeated diagnostic testing. The condition also imposes a substantial burden on owners, often requiring multimodal therapy and frequent veterinary visits over a dog’s lifetime. 

Survey data from 718 veterinarians showed that financial limitations are widespread, with over half reporting that at least 25% of their clients face significant constraints. Most veterinarians routinely incorporate financial considerations into their recommendations. Despite this, core diagnostic approaches—particularly skin cytology and skin scraping—remain consistent regardless of client finances, reflecting their perceived high clinical value. 

Treatment decisions, however, vary more with the financial context. Lower-cost options such as oral corticosteroids are favored when finances are limited, while more advanced therapies like oclacitinib, lokivetmab, and allergen-specific immunotherapy are preferred when cost is not a barrier. Preventive care, especially isoxazoline flea control, is consistently prioritized across scenarios. Antibiotic selection generally aligns with guidelines, with cephalexin commonly preferred, though some concerning deviations persist, including use of fluoroquinolones or amoxicillin in inappropriate contexts. 

The study also highlights gaps between evidence-based recommendations and clinical practice. While most veterinarians are aware of guidelines promoting topical therapy and culture for resistant infections, fewer consistently implement them, often due to cost considerations. Additionally, many clinicians are unfamiliar with newer research, such as shortened elimination diet trials. 

Overall, veterinarians practice along a “spectrum of care,” balancing ideal medical recommendations with client resources, treatment complexity, and adherence. The findings underscore the need for improved education, better cost communication, and strategies to align real-world practice more closely with evolving clinical guidelines.

Gentry, C. M., Rey, L., Rishniw, M., Tater, K., & Teller, L. (2026). Multiple factors, including client financial constraints, play a role in clinician decisions for canine atopic dermatitis: spectrum of care in a chronic and relapsing disease. Journal of the American Veterinary Medical Association https://doi.org/10.2460/javma.25.12.0845 

Bottom line — Improved education and communication are essential.

Just putting things in perspective …